Surveillance needed for potential recurrence of cancer:

Semi-annual PSA until 5 years post-op, then annual PSA; annual digital rectal exam


Surveillance needed for second malignancies:

None


Physicians responsible for monitoring of toxicity, recurrence, second malignancies:

Dr. Smith will be following Mr. Doe for recurrence and will also assess treatment side effects.


Identified psychosocial issues or concerns:

Short-term depression following surgery, resolved with counseling and support group. Assess psychosocial distress during follow-up visits.


Recommended preventive behaviors, interventions, or genetic testing:

Patient counseled regarding diet/exercise (avoidance of obesity). At follow-up visits assess sexual function and depression. Patient given NCI booklet, Life After Cancer Treatment, and the NCCS “Cancer Survival Toolbox: An Audio Resource Program” that address medical and psychosocial issues, including those related to health insurance and employment.


NOTE: All individual and hospital names are fictitious.

SOURCE: Mark Litwin, committee member, 2005.

Example of an End-of-Treatment Consultation Note: Colorectal Cancer

Date of note: April 18, 2005

Name: John Smith Age: 70

Date of tissue diagnosis of cancer: September 15, 2004


Diagnosis: Colon cancer

Stage of cancer: T3N2M0 (IIIB)


Pathologic findings: Moderately differentiated adenocarcinoma penetrating through the muscularis propria. No lymphovascular or perineural invasion. 5/13 regional lymph nodes positive for cancer.


Initial treatment plan:

  • Surgery: Left hemicolectomy 9/28/04

  • Radiation therapy: None

  • Chemotherapy: FOLFOX (5-FU 400 mg/m2 bolus followed by



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement